Key result
The systemic immune-inflammation index (SII) is a reliable biomarker for predicting short-term outcomes, including 30-day mortality (14.8%) and neurological dysfunction (11.1%), after ATAAD repair.
Why the study?
Does the systemic immune-inflammation index predict short-term outcomes in patients undergoing surgery for acute type A aortic dissection?
Population
Patients undergoing surgery for acute type A aortic dissection (ATAAD)
Design
Editorial
Follow-up
30-day
Authors
Loading...
The systemic immune-inflammation index is a promising biomarker for predicting short-term postoperative outcomes and aiding risk stratification in patients undergoing acute type A aortic dissection repair.
Does the systemic immune-inflammation index predict short-term outcomes in patients undergoing surgery for acute type A aortic dissection?
The systemic immune-inflammation index is a promising biomarker for predicting short-term postoperative outcomes and aiding risk stratification in patients undergoing acute type A aortic dissection repair.
Samanidis et al. (2022) conducted an editorial in Acute type A aortic dissection (ATAAD). Systemic immune-inflammation index (SII) was evaluated on Short-term outcomes (30-day mortality and postoperative neurological dysfunctions). The systemic immune-inflammation index (SII) is a reliable biomarker for predicting short-term outcomes, including 30-day mortality (14.8%) and neurological dysfunction (11.1%), after ATAAD repair.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: